Global Herpes Zoste Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Herpes Zoste Drug

• 1.1 Definition of Herpes Zoste Drug
• 1.2 Herpes Zoste Drug Segment by Type
  • 1.2.1 Global Herpes Zoste Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Acyclovir
  • 1.2.3 Amenamevir
  • 1.2.4 FV-100
  • 1.2.5 GLS-5100
  • 1.2.6 GSK-1437173A
  • 1.2.7 NAL-3221
  • 1.2.8 Others
• 1.3 Herpes Zoste Drug Segment by Applications
  • 1.3.1 Global Herpes Zoste Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Clinic
  • 1.3.3 Hospital
  • 1.3.4 Others
• 1.4 Global Herpes Zoste Drug Overall Market
  • 1.4.1 Global Herpes Zoste Drug Revenue (2014-2025)
  • 1.4.2 Global Herpes Zoste Drug Production (2014-2025)
  • 1.4.3 North America Herpes Zoste Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Herpes Zoste Drug Status and Prospect (2014-2025)
  • 1.4.5 China Herpes Zoste Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Herpes Zoste Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Herpes Zoste Drug Status and Prospect (2014-2025)
  • 1.4.8 India Herpes Zoste Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Herpes Zoste Drug
• 2.3 Manufacturing Process Analysis of Herpes Zoste Drug
• 2.4 Industry Chain Structure of Herpes Zoste Drug

3 Development and Manufacturing Plants Analysis of Herpes Zoste Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Herpes Zoste Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Herpes Zoste Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Herpes Zoste Drug Production and Capacity Analysis
• 4.2 Herpes Zoste Drug Revenue Analysis
• 4.3 Herpes Zoste Drug Price Analysis
• 4.4 Market Concentration Degree

5 Herpes Zoste Drug Regional Market Analysis

• 5.1 Herpes Zoste Drug Production by Regions
  • 5.1.1 Global Herpes Zoste Drug Production by Regions
  • 5.1.2 Global Herpes Zoste Drug Revenue by Regions
• 5.2 Herpes Zoste Drug Consumption by Regions
• 5.3 North America Herpes Zoste Drug Market Analysis
  • 5.3.1 North America Herpes Zoste Drug Production
  • 5.3.2 North America Herpes Zoste Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Herpes Zoste Drug Import and Export
• 5.4 Europe Herpes Zoste Drug Market Analysis
  • 5.4.1 Europe Herpes Zoste Drug Production
  • 5.4.2 Europe Herpes Zoste Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Herpes Zoste Drug Import and Export
• 5.5 China Herpes Zoste Drug Market Analysis
  • 5.5.1 China Herpes Zoste Drug Production
  • 5.5.2 China Herpes Zoste Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Herpes Zoste Drug Import and Export
• 5.6 Japan Herpes Zoste Drug Market Analysis
  • 5.6.1 Japan Herpes Zoste Drug Production
  • 5.6.2 Japan Herpes Zoste Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Herpes Zoste Drug Import and Export
• 5.7 Southeast Asia Herpes Zoste Drug Market Analysis
  • 5.7.1 Southeast Asia Herpes Zoste Drug Production
  • 5.7.2 Southeast Asia Herpes Zoste Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Herpes Zoste Drug Import and Export
• 5.8 India Herpes Zoste Drug Market Analysis
  • 5.8.1 India Herpes Zoste Drug Production
  • 5.8.2 India Herpes Zoste Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Herpes Zoste Drug Import and Export

6 Herpes Zoste Drug Segment Market Analysis (by Type)

• 6.1 Global Herpes Zoste Drug Production by Type
• 6.2 Global Herpes Zoste Drug Revenue by Type
• 6.3 Herpes Zoste Drug Price by Type

7 Herpes Zoste Drug Segment Market Analysis (by Application)

• 7.1 Global Herpes Zoste Drug Consumption by Application
• 7.2 Global Herpes Zoste Drug Consumption Market Share by Application (2014-2019)

8 Herpes Zoste Drug Major Manufacturers Analysis

• 8.1 Astellas Pharma Inc.
  • 8.1.1 Astellas Pharma Inc. Herpes Zoste Drug Production Sites and Area Served
  • 8.1.2 Astellas Pharma Inc. Product Introduction, Application and Specification
  • 8.1.3 Astellas Pharma Inc. Herpes Zoste Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Beijing Minhai Biotechnology Co., Ltd
  • 8.2.1 Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Production Sites and Area Served
  • 8.2.2 Beijing Minhai Biotechnology Co., Ltd Product Introduction, Application and Specification
  • 8.2.3 Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 ContraVir Pharmaceuticals, Inc.
  • 8.3.1 ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Production Sites and Area Served
  • 8.3.2 ContraVir Pharmaceuticals, Inc. Product Introduction, Application and Specification
  • 8.3.3 ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Epiphany Biosciences, Inc.
  • 8.4.1 Epiphany Biosciences, Inc. Herpes Zoste Drug Production Sites and Area Served
  • 8.4.2 Epiphany Biosciences, Inc. Product Introduction, Application and Specification
  • 8.4.3 Epiphany Biosciences, Inc. Herpes Zoste Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Foamix Pharmaceuticals Ltd.
  • 8.5.1 Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Production Sites and Area Served
  • 8.5.2 Foamix Pharmaceuticals Ltd. Product Introduction, Application and Specification
  • 8.5.3 Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 GeneOne Life Science, Inc.
  • 8.6.1 GeneOne Life Science, Inc. Herpes Zoste Drug Production Sites and Area Served
  • 8.6.2 GeneOne Life Science, Inc. Product Introduction, Application and Specification
  • 8.6.3 GeneOne Life Science, Inc. Herpes Zoste Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 GlaxoSmithKline Plc
  • 8.7.1 GlaxoSmithKline Plc Herpes Zoste Drug Production Sites and Area Served
  • 8.7.2 GlaxoSmithKline Plc Product Introduction, Application and Specification
  • 8.7.3 GlaxoSmithKline Plc Herpes Zoste Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Merck & Co., Inc.
  • 8.8.1 Merck & Co., Inc. Herpes Zoste Drug Production Sites and Area Served
  • 8.8.2 Merck & Co., Inc. Product Introduction, Application and Specification
  • 8.8.3 Merck & Co., Inc. Herpes Zoste Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 NAL Pharmaceuticals Ltd.
  • 8.9.1 NAL Pharmaceuticals Ltd. Herpes Zoste Drug Production Sites and Area Served
  • 8.9.2 NAL Pharmaceuticals Ltd. Product Introduction, Application and Specification
  • 8.9.3 NAL Pharmaceuticals Ltd. Herpes Zoste Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 ReceptoPharm, Inc.
  • 8.10.1 ReceptoPharm, Inc. Herpes Zoste Drug Production Sites and Area Served
  • 8.10.2 ReceptoPharm, Inc. Product Introduction, Application and Specification
  • 8.10.3 ReceptoPharm, Inc. Herpes Zoste Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 TSRL, Inc.

9 Development Trend of Analysis of Herpes Zoste Drug Market

• 9.1 Global Herpes Zoste Drug Market Trend Analysis
  • 9.1.1 Global Herpes Zoste Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Herpes Zoste Drug Regional Market Trend
  • 9.2.1 North America Herpes Zoste Drug Forecast 2019-2025
  • 9.2.2 Europe Herpes Zoste Drug Forecast 2019-2025
  • 9.2.3 China Herpes Zoste Drug Forecast 2019-2025
  • 9.2.4 Japan Herpes Zoste Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Herpes Zoste Drug Forecast 2019-2025
  • 9.2.6 India Herpes Zoste Drug Forecast 2019-2025
• 9.3 Herpes Zoste Drug Market Trend (Product Type)
• 9.4 Herpes Zoste Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Herpes Zoste Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List